Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 3
2023 3
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.
Armenia D, Marchegiani G, Spagnuolo V, Bellocchi MC, Galli L, Clemente T, Carioti L, Lolatto R, Ferrara M, Gagliardini R, Marchetti GC, Torti C, De Socio G, Fornabaio C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2025 Nov 4;80(11):3101-3106. doi: 10.1093/jac/dkaf349. J Antimicrob Chemother. 2025. PMID: 40990139 Free PMC article.
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
Armenia D, Spagnuolo V, Bellocchi MC, Galli L, Duca L, Marchegiani G, Clemente T, Carioti L, Lolatto R, Calza L, Celesia BM, Cascio A, Francisci D, Saracino A, Torti C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2354-2363. doi: 10.1093/jac/dkae236. J Antimicrob Chemother. 2024. PMID: 39004997
Cancer in people with multidrug-resistant HIV.
Clemente T, Pontillo D, Malagnino V, Calza L, Di Biagio A, Cenderello G, Lolatto R, Manzillo E, Moioli MC, De Socio GV, Castagna A, Spagnuolo V; the PRESTIGIO Study Group. Clemente T, et al. AIDS. 2024 Oct 1;38(12):1801-1806. doi: 10.1097/QAD.0000000000003952. Epub 2024 Aug 29. AIDS. 2024. PMID: 39206886
Inflammation burden score in multidrug-resistant HIV-1 infection.
Clemente T, Caccia R, Galli L, Galli A, Poli A, Marchetti GC, Bandera A, Zazzi M, Santoro MM, Cinque P, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. J Infect. 2023 May;86(5):453-461. doi: 10.1016/j.jinf.2023.03.011. Epub 2023 Mar 11. J Infect. 2023. PMID: 36913985
Sexually transmitted infections in people with multidrug-resistant HIV.
Clemente T, Lolatto R, Papaioannu Borjesson R, Fabbiani M, Manzillo E, Fronti E, Di Giambenedetto S, Gagliardini R, Rusconi S, Santoro MM, Castagna A, Spagnuolo V; on behalf of the PRESTIGIO Study Group. Clemente T, et al. AIDS. 2023 Dec 1;37(15):2425-2430. doi: 10.1097/QAD.0000000000003690. Epub 2023 Nov 16. AIDS. 2023. PMID: 37965740
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.
Papaioannu Borjesson R, Diotallevi S, Lolatto R, Cenderello G, Comi L, Cascio A, Saracino A, Clemente T, Mazzitelli M, Lo Caputo S, Armenia D, Santoro MM, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Papaioannu Borjesson R, et al. J Antimicrob Chemother. 2025 Sep 3;80(9):2369-2374. doi: 10.1093/jac/dkaf211. J Antimicrob Chemother. 2025. PMID: 40693490
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
Clemente T, Diotallevi S, Minisci D, Di Biagio A, Lolatto R, Attala L, Cenderello G, Siribelli A, Muccini C, Lo Caputo S, Tavio M, Papaioannu Borjesson R, Giacomelli A, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. J Antimicrob Chemother. 2025 Mar 3;80(3):731-737. doi: 10.1093/jac/dkae465. J Antimicrob Chemother. 2025. PMID: 39727173
20 results